ID93 + GLA-SE is a recombinant subunit TB vaccine composed of a fusion protein (ID93) consisting of four Mtb antigens (Rv2608, Rv3619, Rv3620, and Rv1813), combined with the TLR-4 agonist adjuvant GLA-SE. This evidence concerns the gene TLR4 and tuberculosis.